June 29, 2023
The 7.5-million grant from the NIH National Institute of Allergy and Infectious Diseases will help researchers pinpoint specific factors that lead to a better immune response through HIV vaccination.
January 28, 2021
Pastor Wil Nichols of Victorious Praise Fellowship Church in Durham, NC, explains why he's participating in the Novavax COVID-19 vaccine clinical trial.
November 5, 2020
Keisha Gibson, MD, MPH, FASN, Department of Medicine Vice Chair of Diversity and Inclusion, shares why she joined a COVID-19 clinical trial and why she's urging others to consider joining the fight.
October 28, 2020
Janeth Pearl, residente de Cary, explica por qué participa en el ensayo clínico de la vacuna COVID-19.
May 23, 2019
The National Institute of Allergy and Infectious Diseases (NIAID) has funded four multi-university cooperative research centers to develop vaccines for chlamydia, syphilis, and gonorrhea. Toni Darville, MD, is the principal investigator on one of them through a grant for up to $10.7 million.
June 14, 2018
A study led by UNC’s Sylvia Becker-Dreps, MD, MPH, reviewed more than 675,000 pregnancies in the U.S. to determine if the Tdap vaccine given to a mother will reduce the chances of her child developing pertussis during the first 18 months of life. The results show a decrease in overall cases of pertussis, and most notably, in pertussis hospitalization in infants whose mothers were immunized during pregnancy.